ABL Diagnostics SA (ABLD) Stock Statistics & Valuation Metrics
Total Valuation
ABL Diagnostics SA has a market cap or net worth of EUR 39.96M. The enterprise value is EUR 45.63M.
- Market Cap
- EUR 39.96M
- Enterprise Value
- EUR 45.63M
Share Statistics
ABL Diagnostics SA has 16,114,656 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 16,114,656
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
ABL Diagnostics SA’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -3.92%.
- Return on Equity (ROE)
- -0.05
- Return on Assets (ROA)
- -0.05
- Return on Invested Capital (ROIC)
- -3.92%
- Return on Capital Employed (ROCE)
- -0.04
- Revenue Per Employee
- 0
- Profits Per Employee
- -6,395.409
- Employee Count
- 22
- Asset Turnover
- ―
- Inventory Turnover
- ―
Valuation Ratios
The current PE Ratio of ABL Diagnostics SA is -4.43. ABL Diagnostics SA’s PEG ratio is 0.08.
- PE Ratio
- -4.43
- PS Ratio
- 0.00
- PB Ratio
- 0.24
- Price to FCF
- -702.94
- Price to Operating Cash Flow
- -10.97
- PEG Ratio
- 0.08
Income Statement
In the last 12 months, ABL Diagnostics SA had revenue of 0 and earned -140.70K in profits. Earnings per share was -0.56.
- Revenue
- 0
- Gross Profit
- -101.64K
- Operating Income
- -102.64K
- Pretax Income
- -102.61K
- Net Income
- -140.70K
- EBITDA
- 295.96K
- Earnings Per Share (EPS)
- -0.56
Cash Flow
In the last 12 months, operating cash flow was -139.20K and capital expenditures 0, giving a free cash flow of -139.20K billion.
- Operating Cash Flow
- -139.20K
- Free Cash Flow
- -139.20K
- Free Cash Flow per Share
- -0.23
Dividends & Yields
ABL Diagnostics SA pays an annual dividend of ―, resulting in a dividend yield of 4.44%
- Dividend Per Share
- ―
- Dividend Yield
- 4.44%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.14%
- Earnings Yield
- -22.63%
Stock Price Statistics
- Beta
- 0.53
- 52-Week Price Change
- -34.04%
- 50-Day Moving Average
- 2.38
- 200-Day Moving Average
- 2.71
- Relative Strength Index (RSI)
- 57.67
- Average Volume (3m)
- 5,608
Important Dates
ABL Diagnostics SA upcoming earnings date is ―, During Market Hours (Confirmed).
- Last Earnings Date
- Sep 08, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
- Current Ratio
- ―
- Quick Ratio
- ―
- Debt to Market Cap
- ―
- Net Debt to EBITDA
- -9.13
- Interest Coverage Ratio
- ―
Taxes
In the past 12 months, ABL Diagnostics SA has paid 38.09K in taxes.
- Income Tax
- 38.09K
- Effective Tax Rate
- ―
Enterprise Valuation
ABL Diagnostics SA EV to EBITDA ratio is 125.52, with an EV/FCF ratio of -655.28.
- EV to Sales
- 0.00
- EV to EBITDA
- 125.52
- EV to Free Cash Flow
- -655.28
- EV to Operating Cash Flow
- -655.28
Balance Sheet
ABL Diagnostics SA has EUR 7.00M in cash and marketable securities with EUR 180.00 in debt, giving a net cash position of EUR 7.00M billion.
- Cash & Marketable Securities
- EUR 7.00M
- Total Debt
- EUR 180.00
- Net Cash
- EUR 7.00M
- Net Cash Per Share
- EUR 0.43
- Tangible Book Value Per Share
- ―
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for ABL Diagnostics SA is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 74.65%
- EPS Growth Forecast
- 327.43%
